Jeffrey Hafkin

Jeffrey Hafkin

Company: Otsuka

Job title: Senior Director


Rational for Targeting APRIL in IgA Nephropathy 1:45 pm

Providing an overview of the Sibeprenlimab development program Reviewing the latest data from the phase 2 trial Optimizing trial design for the phase 3 program: The Visionary Trial DesignRead more

day: Pre-Conference Seminar Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.